Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
NLS Pharmaceutics Ltd. (NLSP) Stock-Based Compensation data is not available for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$2.23M |
|
$0.04M |
|
$0.04M |
|
$2.23M |
|
$0.83M |
|
-- |
|
-- |
|
$0.83M |
|
$-1.33M |
|
$1.41M |
|
$1.41M |
|
-- |
|
| Cash Flow Statement Financials | |
$-4.27M |
|
$-0.00M |
|
$5.04M |
|
$0.90M |
|
$1.67M |
|
$0.77M |
|
|
Stock-Based Compensation |
-- |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|